Appeal No. 2001-1925 Page 6 Application No. 08/677,838 the specification fails to provide an enabling disclosure. The rejection does not set forth other factors, such as the unpredictability of the art or the level of skill in the art that would support the analysis of the pictures in the rejection, and buttress the conclusion that the specification fails to provide an enabling disclosure.1 Thus, the examiner has failed to meet the burden of setting forth a prima facie case of enablement, and the rejection is reversed. OTHER MATTERS Upon return of the application, the examiner may wish to look at the format of claim 1. Claim 1 specifies that the nuclease solution is comprised of components (a), (b) and (c). There is also a limitation of the claim labeled with (d), which would also make it a component of the nuclease, but the limitation is actually drawn to the step of applying the solution to the skin. Thus, it appears as if the “(d)” should be deleted from the beginning of the application step in order to avoid confusion. 1 The two references discussed in the rejection as evidence of the unpredictability of the art, i.e., Tackett and Pacifici, are again directed to the putative theory of operation of the invention, and not the treatment of wrinkles and age spots generally.Page: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007